Diabetes Care Growth Prospects Detailed By Abbott; Prism In Sight
This article was originally published in The Gray Sheet
Executive Summary
Abbott's diabetes care unit will develop into a $1 bil. business within the next two years, according to VP-Investor Relations John Thomas